Spondyloarthritis Research and Treatment Network

Analysis

Spondyloarthritis Research and Treatment Network is a registered charity in United States, based in Portland, OR. It received its IRS tax-exemption ruling in March 2015, 11 years ago. Its declared purposes cover diseases, disorders and medical disciplines, which this site groups under health and saving lives. The IRS classifies it as a publicly supported organisation (donations from the general public) under section 501(c)(3), and contributions to it are listed as tax-deductible.

In the financial year ending July 2023, Spondyloarthritis Research and Treatment Network reported income of $1.1m and spending of $820k, leaving 24% of income unspent that year. Across the 4 years on record, from July 2020 to July 2023, income grew from $1.1m to $1.1m (+2.1%), an average of +0.7% a year. The sharpest change came in the year to July 2022, when income rose by 33%. Over the whole period it spent 114% of the income it received.

Among 40,470 United States charities whose main cause is health and saving lives and that reported income, Spondyloarthritis Research and Treatment Network sits at the 65th percentile: it is larger than about 65% of them. Against every charity in United States with reported income it ranks in the 80th percentile, and in the 81st percentile within OR. Charities of a similar size with the same main cause include The Center for Medical Progress ($1.1m), Parkview Legacy Foundation ($1.1m) and Hospital Sisters Healthcare-West Inc ($1.1m).

On its Form 990 for the period ending July 2023, revenue came from contributions and grants 93% and program service revenue 6.2% of the total. Compensation of current officers, directors and key employees was $116k (14% of expenses). At year end it held assets of $3.0m against liabilities of $202k, net assets of $2.8m.